Ballentine Partners, LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1374889 Waltham, MA

Position in HALO

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$495,526

+$90,814 QoQ

Shares Held

6,331

+1.1% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#36

of 81 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Ballentine Partners, LLC holds $12,066,429 across 29 Biotechnology names. HALO ranks #8 (4.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	5,245	$2,605,347
2	KRYS	Krystal Biotech, Inc.	2,138	$794,629
3	ARGX	Argenx SE	772	$716,237
4	REGN	Regeneron Pharmaceuticals, Inc.	1,054	$657,210
5	INCY	Incyte Corp	4,816	$545,940
6	ALNY	Alnylam Pharmaceuticals, Inc.	1,695	$510,244
7	RPRX	Royalty Pharma plc	9,027	$506,143
8	HALO	Halozyme Therapeutics, Inc. This page	6,331	$495,526

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$495,526	6,331	+1.1%	Shares	Other	2026-07-17
2026-03-31	$404,712	6,262	0.0%	Shares	Other	2026-05-14
2025-12-31	$421,431	6,262	-4.8%	Shares	Other	2026-02-03
2025-09-30	$482,356	6,577	-0.7%	Shares	Other	2025-11-03
2025-06-30	$344,631	6,625	-0.3%	Shares	Other	2025-07-15
2025-03-31	$423,953	6,644	+2.5%	Shares	Other	2025-05-01
2024-12-31	$309,999	6,484	+0.7%	Shares	Other	2025-01-16
2024-09-30	$368,510	6,438	+0.3%	Shares	Other	2024-10-23
2024-06-30	$336,098	6,419	+2.1%	Shares	Other	2024-08-06
2024-03-31	$255,876	6,290	-1.6%	Shares	Other	2024-04-11
2023-12-31	$236,173	6,390	+2.3%	Shares	Other	2024-01-23
2023-09-30	$238,558	6,245	+1.4%	Shares	Other	2023-10-19
2023-06-30	$222,046	6,156	—	Shares	Other	2023-07-26
No filing history on record for this holder in this stock.